2024-07-04 2025-07-31 2025-07-31 false 15819363 NG HEALTH LIMITED 2026-04-02 false iso4217:GBP xbrli:pure 15819363 2024-07-03 15819363 2025-07-31 15819363 2024-07-04 2025-07-31 15819363 2024-07-02 15819363 2024-07-03 15819363 2024-07-03 2024-07-03 15819363 bus:SmallEntities 2024-07-04 2025-07-31 15819363 bus:AuditExempt-NoAccountantsReport 2024-07-04 2025-07-31 15819363 bus:FullAccounts 2024-07-04 2025-07-31 15819363 bus:PrivateLimitedCompanyLtd 2024-07-04 2025-07-31 15819363 core:WithinOneYear 2025-07-31 15819363 core:AfterOneYear 2025-07-31 15819363 core:WithinOneYear 2024-07-03 15819363 core:AfterOneYear 2024-07-03 15819363 core:ShareCapital 2025-07-31 15819363 core:SharePremium 2025-07-31 15819363 core:RevaluationReserve 2025-07-31 15819363 core:OtherReservesSubtotal 2025-07-31 15819363 core:RetainedEarningsAccumulatedLosses 2025-07-31 15819363 core:ShareCapital 2024-07-03 15819363 core:SharePremium 2024-07-03 15819363 core:RevaluationReserve 2024-07-03 15819363 core:OtherReservesSubtotal 2024-07-03 15819363 core:RetainedEarningsAccumulatedLosses 2024-07-03 15819363 core:LandBuildings 2025-07-31 15819363 core:PlantMachinery 2025-07-31 15819363 core:Vehicles 2025-07-31 15819363 core:FurnitureFittings 2025-07-31 15819363 core:OfficeEquipment 2025-07-31 15819363 core:NetGoodwill 2025-07-31 15819363 core:IntangibleAssetsOtherThanGoodwill 2025-07-31 15819363 core:ListedExchangeTraded 2025-07-31 15819363 core:UnlistedNon-exchangeTraded 2025-07-31 15819363 core:LandBuildings 2024-07-03 15819363 core:PlantMachinery 2024-07-03 15819363 core:Vehicles 2024-07-03 15819363 core:FurnitureFittings 2024-07-03 15819363 core:OfficeEquipment 2024-07-03 15819363 core:NetGoodwill 2024-07-03 15819363 core:IntangibleAssetsOtherThanGoodwill 2024-07-03 15819363 core:ListedExchangeTraded 2024-07-03 15819363 core:UnlistedNon-exchangeTraded 2024-07-03 15819363 core:LandBuildings 2024-07-04 2025-07-31 15819363 core:PlantMachinery 2024-07-04 2025-07-31 15819363 core:Vehicles 2024-07-04 2025-07-31 15819363 core:FurnitureFittings 2024-07-04 2025-07-31 15819363 core:OfficeEquipment 2024-07-04 2025-07-31 15819363 core:NetGoodwill 2024-07-04 2025-07-31 15819363 core:IntangibleAssetsOtherThanGoodwill 2024-07-04 2025-07-31 15819363 core:ListedExchangeTraded 2024-07-04 2025-07-31 15819363 core:UnlistedNon-exchangeTraded 2024-07-04 2025-07-31 15819363 core:MoreThanFiveYears 2024-07-04 2025-07-31 15819363 core:Non-currentFinancialInstruments 2025-07-31 15819363 core:Non-currentFinancialInstruments 2024-07-03 15819363 dpl:CostSales 2024-07-04 2025-07-31 15819363 dpl:DistributionCosts 2024-07-04 2025-07-31 15819363 core:LandBuildings 2024-07-04 2025-07-31 15819363 core:PlantMachinery 2024-07-04 2025-07-31 15819363 core:Vehicles 2024-07-04 2025-07-31 15819363 core:FurnitureFittings 2024-07-04 2025-07-31 15819363 core:OfficeEquipment 2024-07-04 2025-07-31 15819363 dpl:AdministrativeExpenses 2024-07-04 2025-07-31 15819363 core:NetGoodwill 2024-07-04 2025-07-31 15819363 core:IntangibleAssetsOtherThanGoodwill 2024-07-04 2025-07-31 15819363 dpl:GroupUndertakings 2024-07-04 2025-07-31 15819363 dpl:ParticipatingInterests 2024-07-04 2025-07-31 15819363 dpl:GroupUndertakings core:ListedExchangeTraded 2024-07-04 2025-07-31 15819363 core:ListedExchangeTraded 2024-07-04 2025-07-31 15819363 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2024-07-04 2025-07-31 15819363 core:UnlistedNon-exchangeTraded 2024-07-04 2025-07-31 15819363 dpl:CostSales 2024-07-03 2024-07-03 15819363 dpl:DistributionCosts 2024-07-03 2024-07-03 15819363 core:LandBuildings 2024-07-03 2024-07-03 15819363 core:PlantMachinery 2024-07-03 2024-07-03 15819363 core:Vehicles 2024-07-03 2024-07-03 15819363 core:FurnitureFittings 2024-07-03 2024-07-03 15819363 core:OfficeEquipment 2024-07-03 2024-07-03 15819363 dpl:AdministrativeExpenses 2024-07-03 2024-07-03 15819363 core:NetGoodwill 2024-07-03 2024-07-03 15819363 core:IntangibleAssetsOtherThanGoodwill 2024-07-03 2024-07-03 15819363 dpl:GroupUndertakings 2024-07-03 2024-07-03 15819363 dpl:ParticipatingInterests 2024-07-03 2024-07-03 15819363 dpl:GroupUndertakings core:ListedExchangeTraded 2024-07-03 2024-07-03 15819363 core:ListedExchangeTraded 2024-07-03 2024-07-03 15819363 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2024-07-03 2024-07-03 15819363 core:UnlistedNon-exchangeTraded 2024-07-03 2024-07-03 15819363 core:NetGoodwill 2025-07-31 15819363 core:IntangibleAssetsOtherThanGoodwill 2025-07-31 15819363 core:LandBuildings 2025-07-31 15819363 core:PlantMachinery 2025-07-31 15819363 core:Vehicles 2025-07-31 15819363 core:FurnitureFittings 2025-07-31 15819363 core:OfficeEquipment 2025-07-31 15819363 core:AfterOneYear 2025-07-31 15819363 core:WithinOneYear 2025-07-31 15819363 core:ListedExchangeTraded 2025-07-31 15819363 core:UnlistedNon-exchangeTraded 2025-07-31 15819363 core:ShareCapital 2025-07-31 15819363 core:SharePremium 2025-07-31 15819363 core:RevaluationReserve 2025-07-31 15819363 core:OtherReservesSubtotal 2025-07-31 15819363 core:RetainedEarningsAccumulatedLosses 2025-07-31 15819363 core:NetGoodwill 2024-07-03 15819363 core:IntangibleAssetsOtherThanGoodwill 2024-07-03 15819363 core:LandBuildings 2024-07-03 15819363 core:PlantMachinery 2024-07-03 15819363 core:Vehicles 2024-07-03 15819363 core:FurnitureFittings 2024-07-03 15819363 core:OfficeEquipment 2024-07-03 15819363 core:AfterOneYear 2024-07-03 15819363 core:WithinOneYear 2024-07-03 15819363 core:ListedExchangeTraded 2024-07-03 15819363 core:UnlistedNon-exchangeTraded 2024-07-03 15819363 core:ShareCapital 2024-07-03 15819363 core:SharePremium 2024-07-03 15819363 core:RevaluationReserve 2024-07-03 15819363 core:OtherReservesSubtotal 2024-07-03 15819363 core:RetainedEarningsAccumulatedLosses 2024-07-03 15819363 core:NetGoodwill 2024-07-02 15819363 core:IntangibleAssetsOtherThanGoodwill 2024-07-02 15819363 core:LandBuildings 2024-07-02 15819363 core:PlantMachinery 2024-07-02 15819363 core:Vehicles 2024-07-02 15819363 core:FurnitureFittings 2024-07-02 15819363 core:OfficeEquipment 2024-07-02 15819363 core:AfterOneYear 2024-07-02 15819363 core:WithinOneYear 2024-07-02 15819363 core:ListedExchangeTraded 2024-07-02 15819363 core:UnlistedNon-exchangeTraded 2024-07-02 15819363 core:ShareCapital 2024-07-02 15819363 core:SharePremium 2024-07-02 15819363 core:RevaluationReserve 2024-07-02 15819363 core:OtherReservesSubtotal 2024-07-02 15819363 core:RetainedEarningsAccumulatedLosses 2024-07-02 15819363 core:AfterOneYear 2024-07-04 2025-07-31 15819363 core:WithinOneYear 2024-07-04 2025-07-31 15819363 core:Non-currentFinancialInstruments core:CostValuation 2024-07-04 2025-07-31 15819363 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2024-07-04 2025-07-31 15819363 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2024-07-04 2025-07-31 15819363 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2024-07-04 2025-07-31 15819363 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2024-07-04 2025-07-31 15819363 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2024-07-04 2025-07-31 15819363 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2024-07-04 2025-07-31 15819363 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2024-07-04 2025-07-31 15819363 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2024-07-04 2025-07-31 15819363 core:Non-currentFinancialInstruments core:CostValuation 2025-07-31 15819363 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2025-07-31 15819363 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2025-07-31 15819363 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2025-07-31 15819363 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2025-07-31 15819363 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2025-07-31 15819363 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2025-07-31 15819363 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2025-07-31 15819363 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2025-07-31 15819363 core:Non-currentFinancialInstruments core:CostValuation 2024-07-03 15819363 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2024-07-03 15819363 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2024-07-03 15819363 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2024-07-03 15819363 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2024-07-03 15819363 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2024-07-03 15819363 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2024-07-03 15819363 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2024-07-03 15819363 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2024-07-03 15819363 bus:Director1 2024-07-04 2025-07-31

NG HEALTH LIMITED

Registered Number
15819363
(England and Wales)

Unaudited Financial Statements for the Period ended
31 July 2025

NG HEALTH LIMITED
Company Information
for the period from 4 July 2024 to 31 July 2025

Director | NORA GHAILAN

Registered Address | C/O Cwa Lockkeepers Cottage
| Unit 36, Hazelmere Marina
| Waltham Abbey
| EN9 1FJ

Registered Number | 15819363 (England and Wales)

NG HEALTH LIMITED
Balance Sheet as at
31 July 2025

| Notes | 2025
--- | --- | ---
|  | £ |  | £
Current assets |  |  |  |
Debtors |  | 38 |  |
Cash at bank and on hand |  | 14,020 |  |
|  | 14,058 |  |
Creditors amounts falling due within one year |  | (7,602) |  |
Net current assets (liabilities) |  |  |  | 6,456
Total assets less current liabilities |  |  |  | 6,456
Net assets |  |  |  | 6,456
Capital and reserves |  |  |  |
Called up share capital |  |  |  | 100
Profit and loss account |  |  |  | 6,356
Shareholders' funds |  |  |  | 6,456

- The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
- The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
- The Director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
- These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
- The directors have chosen to not file a copy of the company’s profit and loss account under section 444 (5A) Companies Act 2006.

The financial statements were approved and authorised for issue by the Director on 2 April 2026, and are signed on its behalf by:
NORA GHAILAN Director Registered Company No. 15819363

NG HEALTH LIMITED
Notes to the Financial Statements
for the period ended 31 July 2025

1. | Accounting policies
--- | ---

| Statutory information
--- | ---
| The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

| Statement of compliance
--- | ---
| The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.

| Basis of preparation
--- | ---
| The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).

| Turnover policy
--- | ---
| Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.

| Revenue from rendering of services
--- | ---
| Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.

2. | Average number of employees
--- | ---

|  | 2025
| Average number of employees during the year | 2

3. | Controlling party
--- | ---
| The company considers Nora Ghailan to be its ultimate controlling party.